Cargando…

Tracing the genetic fingerprints of tumour evolution: The pursuit of identifying mutations with differential weights within the overall tumour mutation burden and their role in therapeutic responses with immune checkpoint blockade

Detalles Bibliográficos
Autores principales:	Niknafs, Noushin, Conroy, Michael, Anagnostou, Valsamo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230153/ https://www.ncbi.nlm.nih.gov/pubmed/37254649 http://dx.doi.org/10.1002/ctm2.1287

Ejemplares similares

Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade
por: Mahmood, Mahnoor, et al.
Publicado: (2023)

Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
por: Scott, Susan C., et al.
Publicado: (2022)

Bias and inconsistency in the estimation of tumour mutation burden
por: Makrooni, Mohammad A., et al.
Publicado: (2022)

Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade
por: Appleton, Elizabeth, et al.
Publicado: (2021)

Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis
por: Xiang, Xuemei, et al.
Publicado: (2022)

Persistent mutation burden drives sustained anti-tumor immune responses
por: Niknafs, Noushin, et al.
Publicado: (2023)

Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better
por: Zheng, Ming
Publicado: (2022)

Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade
por: Yoo, Seong-Keun, et al.
Publicado: (2022)

Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens
por: Gubin, Matthew M., et al.
Publicado: (2014)

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
por: Anagnostou, Valsamo, et al.
Publicado: (2020)

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
por: Mankor, Joanne M., et al.
Publicado: (2020)

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours
por: Brown, V L, et al.
Publicado: (2002)

The influence of tumour mutational burden on renal cancer immune infiltration and survival
por: Byrne, Matthew H. V., et al.
Publicado: (2020)

Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
por: Conche, Claire, et al.
Publicado: (2023)

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
por: Xiong, Zhewen, et al.
Publicado: (2023)

Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer
por: Wang, Lijuan, et al.
Publicado: (2021)

Tumour mutational burden: primary versus metastatic tissue creates systematic bias
por: Schnidrig, Desiree, et al.
Publicado: (2019)

Heterogeneity of tumour mutational burden in metastatic NSCLC demonstrated by endobronchial ultrasound sampling
por: Leong, Tracy L., et al.
Publicado: (2023)

Dose-Dependent Effect of Tumor Mutation Burden on Cancer Prognosis Following Immune Checkpoint Blockade: Causal Implications
por: Zheng, Ming
Publicado: (2022)

Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden
por: Stockton, Joanne D., et al.
Publicado: (2021)

Mutated genes, pathways and processes in tumours
por: Baudot, Anaïs, et al.
Publicado: (2010)

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China
por: Chen, Yanhui, et al.
Publicado: (2020)

Cancer Mutational Load: The More the Merrier for Immune Checkpoint Blockade Therapies
Publicado: (2016)

Role of tumor gene mutations in treatment response to immune checkpoint blockades
por: Wang, Manni, et al.
Publicado: (2019)

Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
por: Yue, Wenwen, et al.
Publicado: (2019)

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

Tumour purity as an underlying key factor in tumour mutation detection in colorectal cancer
por: Yu, Tao, et al.
Publicado: (2023)

Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
por: Gu, Shengqing Stan, et al.
Publicado: (2020)

Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors
por: Xavier, Camila B., et al.
Publicado: (2022)

Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients
por: Guo, Gang, et al.
Publicado: (2021)

Clinicopathological Features, Tumor Mutational Burden, and Tumour-Infiltrating Lymphocyte Interplay in ERBB2-Mutated Breast Cancer: In Silico Analysis
por: Uchida, Shiro, et al.
Publicado: (2021)

Mutations in normal breast tissue and breast tumours
por: Tomlinson, Ian PM
Publicado: (2001)

Mutation divergence over space in tumour expansion
por: Li, Haiyang, et al.
Publicado: (2023)

Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity
por: Langdon, Sophie, et al.
Publicado: (2018)

Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score
por: Liu, Si-Yang Maggie, et al.
Publicado: (2021)

Mutation of the Conserved Threonine 8 within the Human ARF Tumour Suppressor Protein Regulates Autophagy
por: Fontana, Rosa, et al.
Publicado: (2022)

SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice
por: Casey, Ruth T., et al.
Publicado: (2019)

Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients
por: Liu, Chunnan, et al.
Publicado: (2022)

Heterogeneity in clone dynamics within and adjacent to intestinal tumours identified by Dre-mediated lineage tracing
por: Thorsen, Ann-Sofie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aavamdm0allv5pmp0bca50osmr